Founding director and Exonate’s CSO, Professor David Bates is returning to Portugal as a plenary speaker at the 2nd International Conference on Splicing in Caparica, Portugal from 16-19th July. The team are presenting data on development of novel inhibitors of alternative splicing.
There will also be oral contributions from Exonate’s founding scientist Dr Lucy Donaldson. She will be discussing developing systemically active spicing kinase SRPK1 inhibitors as anti-inflammatory/analgesic drugs.
Exonate’s Professor of Chemistry with the UNSW Australia will be addressing the Development of Small Molecule Inhibitors of RNA Splicing Kinases.
Exonate’s team members are available for meetings whilst there and contact can be made via Louise Shave. Louise.shave@exonate.com.